Unilever’s Baby Dove wash and lotion has fallen foul of guidelines set by the UK’s ad watchdog, which ruled the product does not benefit the skin microbiome, unless proof
can be presented.
In the ruling dated 13 Jan 2021, The Advertising Standards Authority (ASA) stated the social media ad, used a series of statements suggesting the product could “nourish” a baby’s skin microbiome.
Responding to accusations the ad was misleading and could not be substantiated, Unilever said the claims did not state or imply the products could be used to make a medical diagnosis or treat or prevent disease, including injury, ailment or adverse condition.
By Will Chu – 12 Jan 2021
GBA Group is a leading group of laboratories with a solid reputation backed by over…
Now, INTECH CO. developed stripping tape to collect Dead skin cell. - Basic Skin Research…
K-Beauty's Global Takeover: A Success Story The Korean beauty industry has achieved an unprecedented milestone:…